Cargando…
Iron status influences the response of cord blood megakaryocyte progenitors to eltrombopag in vitro
Eltrombopag (ELT) is a thrombopoietic agent approved for immune thrombocytopenia and also a potent iron chelator. Here we found that ELT exhibited dose-dependent opposing effects on in vitro megakaryopoiesis: low concentrations (≤6 µM, ELT6) stimulated megakaryopoiesis, but high concentrations (30 µ...
Autores principales: | Liu, Zhi-Jian, Deschmann, Emoke, Ramsey, Haley E., Feldman, Henry A., Psaila, Bethan, Cooper, Nichola, Vlachodimitropoulou, Evangelia, Porter, John, Bussel, James, Georgieff, Michael, Sola-Visner, Martha |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Hematology
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8753208/ https://www.ncbi.nlm.nih.gov/pubmed/34654056 http://dx.doi.org/10.1182/bloodadvances.2021004207 |
Ejemplares similares
-
Cost-effectiveness of eltrombopag vs intravenous immunoglobulin for the perioperative management of immune thrombocytopenia
por: Kaur, Manraj N., et al.
Publicado: (2022) -
Eltrombopag in patients with chronic immune thrombocytopenia in Asia-Pacific, the Middle East, and Turkey: final analysis of CITE
por: Wong, Raymond Siu Ming, et al.
Publicado: (2022) -
The RNA-binding protein SRSF3 has an essential role in megakaryocyte maturation and platelet production
por: Heazlewood, Shen Y., et al.
Publicado: (2022) -
Src-related thrombocytopenia: a fine line between a megakaryocyte dysfunction and an immune-mediated disease
por: Palma-Barqueros, Verónica, et al.
Publicado: (2022) -
Matrix stiffness controls megakaryocyte adhesion, fibronectin fibrillogenesis, and proplatelet formation through Itgβ3
por: Guinard, Ines, et al.
Publicado: (2023)